Click to copy
Click to copy

Flexion Therapeutics: 2Q Earnings Snapshot

August 6, 2019

BURLINGTON, Mass. (AP) _ Flexion Therapeutics Inc. (FLXN) on Tuesday reported a loss of $36.5 million in its second quarter.

The Burlington, Massachusetts-based company said it had a loss of 96 cents per share.

The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of $1.06 per share.

The specialty pharmaceutical companies that specializes in pain relief posted revenue of $17 million in the period, also topping Street forecasts. Three analysts surveyed by Zacks expected $14 million.

Flexion Therapeutics shares have decreased 19% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $9.14, a decrease of 60% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FLXN at https://www.zacks.com/ap/FLXN

All contents © copyright 2019 The Associated Press. All rights reserved.